Former Republican Congressman Billy Tauzin commenced work as the head of the Pharmaceutical Research and Manufacturers of America (PhRMA) in early January 2005. Tauzin is also registered as a lobbyist for PhRMA. 
Tauzin was criticised by Democrats early in 2004 when it was rumoured he was negotiating with the drug industry over a possible job. Tauzin had spent almost a full year shepherding the Medicare Prescription Drug Benefit Bill through Congress. The pharmaceutical industry will reap windfall profits from the Medicare drug bill.
Tauzin resigned as chairman of the House Energy and Commerce Committee, which has oversight of the drug industry, and did not re-contest his seat in the November 2004 eleection. In December 2004 PhRMA confirmed that Tauzin would head the organization. 
USA Today reported in January 2005 that Tauzin's pay package is rumoured to be greater than $2 million a year. 
|Documents Contained at the Anti-Environmental Archives|
Documents written by or referencing this person or organization are contained in the Anti-Environmental Archive, launched by Greenpeace on Earth Day, 2015. The archive contains 3,500 documents, some 27,000 pages, covering 350 organizations and individuals. The current archive includes mainly documents collected in the late 1980s through the early 2000s by The Clearinghouse on Environmental Advocacy and Research (CLEAR), an organization that tracked the rise of the so called "Wise Use" movement in the 1990s during the Clinton presidency. Access the index to the Anti-Environmental Archives here.
Other SourceWatch resources
- "Drug Trade Group Spent $10.7M Lobbying", Associated Press, August 17, 2007.
- Judy Sarasohn, "Tauzin to Head Drug Trade Group", Washington Post, December 16, 2004.
- William M. Welch, "Tauzin switches sides from drug industry overseer to lobbyist", USA TODAY, December 15, 2004.
- Frank Ahrens, "24 Tauzin Expected To Leave House For Trade Group. Lawmaker Declined Hollywood Job", Washington Post, January 2004: "Rep. W.J. Billy Tauzin (R-La.) is close to a decision to leave Congress to head the pharmaceutical industry's trade association (Pharmaceutical Research and Manufacturers of America (PhRMA), the trade group that represents drug giants such as Pfizer Inc. and Merck & Co.) after turning down an offer from Hollywood to succeed Jack Valenti as the movie industry's top lobbyist, sources in Washington and California said yesterday."
- Jeanne Lenzer, "Ties between regulators and business are attacked after politician takes top job in industry", British Medical Journal, Volume 330, No 7842, January 8, 2005.